INDUSTRY INSIGHT
EYE CARE
SPONSORED CONTENT
FIRST PRACTICE IN PA TO OFFER 3D
MICROSCOPIC RETINAL SURGERY
— Innovative Technology Off ering Better Surgical Outcomes and Interventions —
Off ers enhanced 3D visualization with high-defi nition resolution, image depth, clarity and color contrast
while helping to minimize light exposure to the patient’s eye
AIO (Associates in Ophthalmology) , Pittsburgh’s trusted
ophthalmologists, is the fi rst practice in Pennsylvania to off er patients
the 3D assisted microscopic retinal surgical technology, the NGENUITY®
System.
The NGENUITY® 3D Visualization System is designed for more effi cient
surgery via better visualization of the retina anatomy. Alcon launched
the system in collaboration with TrueVision®3D Surgical, a California-
based company specializing in digital 3D visualization and guidance for
microsurgery.
The NGENUITY 3D Visualization System is comprised of several
elements, notably a High Dynamic Range (HDR) camera that provides
excellent resolution, image depth, clarity and color contrast. With the
three-dimensional view,
the surgeon now has depth
perception not previously
available on standard
television monitors, often
used today in the operation theatre. Surgeons may also increase
magnifi cation while maintaining a wide fi eld of view as well as use
digital fi lters to customize his or her view during each procedure,
highlighting ocular structures and tissue layers, which is imperative
to visualize the back of the eye. Engineered with a specifi c focus on
minimizing light exposure to the patient’s eye, the NGENUITY 3D
Visualization System facilitates operating using lower light levels.
“This digital platform off ers more than just enhanced visualization.
It will impact our therapies and the way we manipulate tissue,” said Dr.
Allen Ho, Professor of Ophthalmology, Thomas Jeff erson University, and
Director of Retina Research, Wills Eye Hospital, Philadelphia. “The easier
it is for surgeons to perform these long, delicate surgeries, the better
they can perform for our patients who count on us to provide them
with the best possible care.”
“At AIO, we are fi nding that the use of this technology is enabling us
to perform retinal surgeries once deemed impossible,” said Dr. Miguel
Busquets, Vitreoretinal Surgeon and Director of the Division of Research
and Clinical Trials at AIO. “The system allows for better outcomes due to
the signifi cantly improved resolution of tissue visualization under high
magnifi cation.”
The system is designed to facilitate collaboration and teaching in the
o